Recce Pharmaceuticals advances diabetec foot infection trial
Recce Pharmaceuticals (ASX:RCE) received ethical approval to advance its Australian diabetic foot infection trial to a 200-patient Phase 3 study.
Recce Pharmaceuticals (ASX:RCE) received ethical approval to advance its Australian diabetic foot infection trial to a 200-patient Phase 3 study.
XRP (CRYPTO:XRP) briefly broke below the closely watched US$1.14 support level on Sunday before buyers stepped in, driving the token from a low near US$1.12 back toward US$1.15.
Taiko (CRYPTO:TAIKO) has advised users to withdraw assets from all bridges deployed on its network after an exploit targeting its chain state verification mechanism resulted in losses estimated at up to US$1.7 million.
Morgan Stanley has amended its filings for proposed Ethereum (CRYPTO:ETH) and Solana (CRYPTO:SOL) exchange-traded funds, revealing plans to charge management fees of 0.14% for both products.
Mineral Resources (ASX:MIN) announced an updated executive succession plan following a leadership assessment by recruitment firm Korn Ferry.
Franklin Templeton has filed plans with the US Securities and Exchange Commission for two exchange-traded funds that combine US equities with Bitcoin (CRYPTO:BTC) exposure through dividend reinvestment.
KPMG has submitted a first tranche of internal investigation documents to an Australian parliamentary committee.
Polygon (CRYPTO:POL) processed US$309 million in Latin American stablecoin volume during May, with co-founder Sandeep Nailwal stating the network led the region in stablecoin activity.
Eden Innovations (ASX:EDE) reported trial results from India showing its concrete admixture achieved up to a 20% strength increase.
Senator Cynthia Lummis said the Digital Asset Market Clarity Act would protect crypto developers from prosecution for writing code if they do not custody or control customer funds.
GARANTA JÁ SEU GRAFA EDGE
Sign up free to unlock this feature
Vamos ativar um teste de 30 dias do Edge como presente de boas-vindas